Published in Eur J Clin Pharmacol on July 14, 2007
Antiobesity pharmacotherapy: new drugs and emerging targets. Clin Pharmacol Ther (2013) 1.09
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity. Diabetes Metab Syndr Obes (2013) 0.82
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet (2003) 4.79
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol (2007) 1.54
Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia (2000) 1.48
The specificity of restrained versus unrestrained eaters' responses to food cues: general desire to eat, or craving for the cued food? Appetite (2003) 1.22
A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry (2003) 1.15
Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry (2004) 0.99
Topiramate for smoking cessation. Psychiatry Clin Neurosci (2006) 0.98
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol (2005) 0.97
Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Psychopharmacology (Berl) (2003) 0.82
Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry (2006) 0.78
Khat use: lifestyle or addiction? J Psychoactive Drugs (2009) 1.05
Internet use by patients with psychiatric disorders in search for general and medical informations. Psychiatr Q (2008) 1.05
Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey. Eur Addict Res (2011) 1.00
Topiramate for smoking cessation. Psychiatry Clin Neurosci (2006) 0.98
Psychological predictors of problematic involvement in massively multiplayer online role-playing games: illustration in a sample of male cybercafé players. Psychopathology (2011) 0.97
Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin. Subst Abus (2004) 0.94
Quality of web-based information on bipolar disorder. J Affect Disord (2008) 0.94
Validation of a short French version of the UPPS-P Impulsive Behavior Scale. Compr Psychiatry (2011) 0.92
Quality of Web-based information on depression. Depress Anxiety (2010) 0.90
Acute generalized exanthematous pustulosis induced by olanzapine. Acta Medica (Hradec Kralove) (2006) 0.89
Lack of inhibitory control predicts cigarette smoking dependence: evidence from a non-deprived sample of light to moderate smokers. Drug Alcohol Depend (2010) 0.88
Trait gambling cognitions predict near-miss experiences and persistence in laboratory slot machine gambling. Br J Psychol (2011) 0.88
Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) (2004) 0.87
The relationship between addiction and religion and its possible implication for care. Subst Use Misuse (2010) 0.85
Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST). Eur Addict Res (2011) 0.84
The Beck Cognitive Insight Scale in outpatients with psychotic disorders: further evidence from a French-speaking sample. Can J Psychiatry (2008) 0.84
Bupropion-induced somnambulism. Addict Biol (2003) 0.83
A follow-up study on the quality of alcohol dependence-related information on the web. Subst Abuse Treat Prev Policy (2011) 0.83
Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol (2005) 0.81
Quality of Web-based information on obsessive compulsive disorder. Neuropsychiatr Dis Treat (2013) 0.81
Psychopharmacological treatment in pathological gambling: a critical review. Curr Pharm Des (2011) 0.81
Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia? J Nerv Ment Dis (2009) 0.80
[Assessing the quality of French language web sites pertaining to alcohol dependency]. Sante Ment Que (2008) 0.80
Stage of change of cigarette smoking in drug dependent patients. Swiss Med Wkly (2004) 0.80
Alcohol-related brief intervention in patients treated for opiate or cocaine dependence: a randomized controlled study. Subst Abuse Treat Prev Policy (2011) 0.79
Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST) in the elderly. Subst Abuse Treat Prev Policy (2012) 0.79
Local back massage with an automated massage chair: general muscle and psychophysiologic relaxing properties. J Altern Complement Med (2005) 0.79
Impact of psychiatrists' qualifications on the rate of compulsory admissions. Psychiatr Q (2013) 0.78
Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry (2006) 0.78
Cannabis and psychosis. Lancet (2007) 0.78
[Psychoeducational and cognitive behavioral treatments of bipolar disorder]. Sante Ment Que (2006) 0.77
Naltrexone-assisted rapid methadone discontinuation: a pilot study. Eur Addict Res (2007) 0.77
Swiss psychiatrists' beliefs and attitudes about internet addiction. Psychiatr Q (2009) 0.77
The Geneva Appetitive Alcohol Pictures (GAAP): development and preliminary validation. Eur Addict Res (2011) 0.77
Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.76
Cannabis and the course of schizophrenia. Am J Psychiatry (2008) 0.76
The potential interest of topiramate in addiction. Curr Pharm Des (2011) 0.76
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. Br J Clin Pharmacol (2005) 0.75
Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms. J Clin Psychopharmacol (2009) 0.75
Swiss psychiatrists beliefs and attitudes about cannabis risks in psychiatric patients: ideologically determined or evidence-based? Community Ment Health J (2007) 0.75
Parkinson's disease masked by clozapine: a case report. Gen Hosp Psychiatry (2004) 0.75
Depersonalization-derealization syndrome induced by reboxetine. Swiss Med Wkly (2003) 0.75
Quality of Smartphone Apps Related to Alcohol Use Disorder. Eur Addict Res (2016) 0.75
Tragic logic or how evidence does not change convictions: the perception of Geneva's addictology caregivers concerning the utility of disulfiram. J Addict Nurs (2012) 0.75
Obsessive-compulsive symptoms precipitated by methadone tapering. J Clin Psychopharmacol (2004) 0.75
[Pharmacotherapy of anxiety in the addicted patient]. Rev Med Suisse Romande (2004) 0.75
[Addiction]. Rev Med Suisse (2015) 0.75
[A metaphor of the nurse's work in addictology]. Soins Psychiatr (2011) 0.75
[The quality of Internet medical sites]. Rev Med Suisse (2007) 0.75
Escitalopram/reboxetine combination in depressed patients with substance use disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.75
Worsening of obsessive-compulsive symptoms under methadone tapering. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.75
Pornographic effect of olanzapine: induction of vivid intrusive sexual obsessional images. Gen Hosp Psychiatry (2006) 0.75
Hemi-depersonalization syndrome. Int J Psychiatry Clin Pract (2005) 0.75
Venlafaxine versus applied relaxation for generalized anxiety disorder: a randomized controlled study on clinical and electrophysiological outcomes. Psychiatr Q (2015) 0.75
[Depersonalization--current data]. Can J Psychiatry (2005) 0.75
Understanding Swiss drug policy change and the introduction of heroin maintenance treatment. Eur Addict Res (2014) 0.75
Reduced valproate plasma levels possible after introduction of efavirenz in a bipolar patient. Bipolar Disord (2006) 0.75
The "rut metaphor": a conceptualization of attractor-shaping properties of addictive drugs. Subst Use Misuse (2008) 0.75
[How hypervigilance and hyperreactivity clinically described in anxiety expressed physiologically?]. Sante Ment Que (2004) 0.75
Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. Ann Pharmacother (2007) 0.75
Ether: a forgotten addiction. Addiction (2003) 0.75